Nathalie Clement BS, PhD

Dr Clément gained extensive knowledge in both the Gene Therapy and Parvovirus fields during her PhD work and post-doctoral fellowship, with a special emphasis on the development of AAV-based vectors for Gene Therapy applications. She ran a core facility in the Mount Sinai Hospital where she was in charge of supervising the development of many new AAV-based vectors including their production, purification and quality control assays. She was recently recruited to the PGTC where she continues to dedicate her research to the development of AAV vectors for research and clinical projects.